News list for "pharma"
Quantum BioPharma (NASDAQ: QNTM) today announced financial results for the third quarter of 2025, showing a significant strengthening of the company's finances, with a 275% sequential increase in shareholders' equity, a 50% reduction in total liabilities, and an 87% decrease in debt-to-equity ratio. The company's digital asset portfolio, primarily bitcoin, has realized $572,000 in gains, and total digital assets have increased from $800,000 at the end of 2024 to $5.20 million today.
Quantum BioPharma（纳斯达克股票代码：QNTM）今日公布2025年第三季度财务业绩，显示公司财务状况显著增强，股东权益环比增长275%，总负债减少50%，债务权益比率下降87%。公司数字资产组合（主要为比特币）已实现57.2万美元收益，数字资产总额从2024年底的80万美元增至当前520万美元。
On November 4th, according to Globenewswire, digital asset finance company Propanc Biopharma (NASDAQ: PPCB) announced a strategic plan to acquire digital asset management (DAT) companies that are currently trading below their market capitalization-to-net asset value (MNAV) ratios. Company management believes that the acquisition of undervalued digital asset technology (DAT) companies is a way to strengthen Propanc's balance sheet, diversify its assets and create long-term stocks...
11月4日消息，据Globenewswire报道，数字资产财务公司Propanc Biopharma（纳斯达克股票代码：PPCB）宣布了一项战略计划，旨在收购目前市值与净资产值之比（MNAV）低于其交易的数字资产管理（DAT）公司。公司管理层认为，收购被低估的数字资产技术（DAT）公司是增强Propanc资产负债表、实现资产多元化并创造长期股...
On October 15th, Propanc Biopharma, a biopharmaceutical company that adopts the Ethereum treasury strategy, announced a strategic financing agreement of up to $100 million with the family office Hexstone Capital. Propanc CEO James Nathanielsz said that the financing will accelerate the development of the company's clinical pipeline and plans to grow the value of the digital asset library to $100 million or more in the next 12 months. Hexstone Capital has previously invested in several companies ...
10 月 15 日消息，采用以太坊财库战略的生物制药公司 Propanc Biopharma 宣布与家族办公室 Hexstone Capital 达成最高 1 亿美元的战略融资协议。 Propanc CEO James Nathanielsz 表示，此次融资将加速公司临床管线开发，并计划在未来 12 个月内将数字资产库价值增长至 1 亿美元或以上。Hexstone Capital 此前已投资多家拥有数字资产库的公司，涉及 BTC、ETH、SOL、DOGE 等多种数字资产。 此前消息，九月初...
Listed company Sunshine Biopharma (SBFM) has spent $5 million on bitcoin in an effort to bolster its company finances.
上市公司 Sunshine Biopharma（SBFM）已斥资 500 万美元购买比特币，旨在增强其公司财务弹性。
US-listed Litecoin reserve company MEI Pharma has announced the change of its name to Litecoin Strategy (Nasdaq: LITS).
美股上市的莱特币储备公司 MEI Pharma 宣布更名为 Litecoin Strategy(Nasdaq: LITS)。
